Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Travelers Indemnity Company et al v. Pfizer Inc. et al
Case Number:
3:12-cv-01059
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 26, 2013
Travelers Says Claims Not Time-Barred In $47M Pfizer Suit
Travelers Indemnity Co. on Monday asked a federal judge not to toss its $47 million lawsuit claiming it overpaid Pfizer Inc. for the epilepsy drug Neurontin due to the drugmaker's anti-competitive efforts and aggressive marketing of off-label uses, saying its claims are not time-barred.
-
July 18, 2012
Travelers Sues Pfizer For $47M Over Epilepsy Drug
Travelers Indemnity Co. and several of its affiliates on Wednesday filed a $47 million suit against Pfizer Inc. claiming they overpaid for epilepsy drug Neurontin because of its anti-competitive efforts to keep generics out of the market and its aggressive marketing of off-label uses.